LTRNLantern Pharma Inc.Downtrend

TodayDowntrendjumpy stock

Nasdaq CMBiotechnologyMarket cap $9.32MReports Nov 11, 2026

0.62−1.76% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

AI summary

The LTRN read, in plain language

The AI summary distills LTRN's accumulation, technical and fundamental reads into a few plain-language sentences, generated fresh after you unlock.

In the full analysis:

Full narrative & key driversLocked
Technicals readLocked
Fundamentals readLocked
Accumulation readLocked
Risks with evidenceLocked
Market context readLocked

Unlock LTRN: AI summary

Technical readingsFree

Downtrend, washed-outSee the full setup read: unlock LTRN

Trend state Downtrend, stage 4 of 4, 3 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading below its key moving averages and momentum readings are washed out: recent selling pressure has been heavy. RSI is currently 20.

Readings, end-of-day Oct 26, 2026

RSI (14)Oversold zone19.76

MACD / signalAbove signal line-0.24 / -0.27

SMA 50Price below1.44

SMA 200Price below2.52

EMA 20Price below0.84

ADX (14)Trending56.61

Show all 12 readings

+DI / −DI−DI leading5.68 / 31.26

ATR (14)13.6% of price — elevated daily swings0.08

Stochastic %KOversold zone8.02

Bollinger bands (20)Inside bands0.49 – 1.09

ROC (10)Negative over 10 sessions-15.36

Trend / momentum impulseTrend and momentum disagreeMixed

How different investors read thisNo verdict. Ever.

Long-term holder

Add or trim?

Short-term trader

Enter or wait?

Not yet invested

Start or skip?

Looking ahead

What has to go right?

Each horizon shown is argued both ways; unlocking shows the points behind both sides.

Evidence from this report, not a recommendation.

Unlock LTRN: the full evidence

Full analysis

What unlocking LTRN reveals

Short term · weeksMomentum washed-outMid term · monthsDowntrend, washed-outLong term · business qualityWeakMarket linkshows little relationship with the S&P 500

These classifications are computed from LTRN's live data. The detail behind them is what unlocks.

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock

Signals & levelsSignals computed from this stock's own price bands, each naming the sessions behind it.

Signal history23 volume signals in the past year; the median 3-month move after them was −5.30%, positive 12 of 23 times.

AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock

Catalysts & risksNext earnings dated Nov 11, 2026; risks paired to the figures behind them.

Fundamentals & valuationThe fundamentals read weak; the full table shows every input.

Market context & correlationsShows little relationship with the S&P 500; the full table names each instrument and window.

Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when LTRN's analysis runs, rather than checked against its stored data now.

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock

Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock

AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock

Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock

Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when LTRN's analysis runs, rather than checked against its stored data now.

Every section above, argued on LTRN's own numbers, on one page.

See what LTRN costs Not sure what's inside? Read a full TSLA analysis, currently free

Unlock the full LTRN analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

Unlocked in about 60 seconds
No account needed
Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get LTRN + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.

Build a dataset

Earnings

When does Lantern Pharma Inc. report earnings?

Lantern Pharma Inc. (LTRN) is scheduled to report earnings on Nov 11, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon

Not investment advice. Everything on this page is descriptive market data and automated analysis provided for information only. It is not a recommendation, offer, or solicitation to buy or sell any security, and it does not account for your personal circumstances. Figures are from an end-of-day snapshot and may be delayed or restated; always verify against a primary source before acting. You are solely responsible for your own decisions.

About the signals.Buy and sell signals on this page are computed automatically from this stock’s own past price history: they summarise what happened after similar sessions, over the window each signal states. They are measurements of the past, not predictions, forecasts, or targets, and past behaviour does not determine future results. A signal is never a suggestion that you take any action.

Data dictionary

$9.90one-time Unlock LTRN

The LTRN read, in plain language

Technical readingsFree

How different investors read thisNo verdict. Ever.

Long-term holder

Short-term trader

Not yet invested

Looking ahead

What unlocking LTRN reveals

Unlock the full LTRN analysis

More Healthcare stocks

Put LTRN next to a peer

When does Lantern Pharma Inc. report earnings?

How different investors read thisNo verdict. Ever.

Long-term holder

Short-term trader

Not yet invested

Looking ahead

The LTRN read, in plain language